Goodwin Pharma Services Symposium

October 20–21, 2026 | Boston, MA

Pharma services has emerged as one of the most active and rapidly evolving sectors across healthcare and life sciences. The inaugural Goodwin Pharma Services Symposium brought together company executives, private capital providers, investment bankers, advisers, and other industry leaders for timely conversations, meaningful connections, and new partnership opportunities.

The symposium began with an evening welcome reception on October 20, followed by a half-day forum on October 21. Through panel discussions, a keynote conversation, and dedicated networking opportunities, the program examined the market, transactional, operational, regulatory, and technological forces transforming the pharma services ecosystem.

We were pleased to welcome attendees to Boston for this flagship event, which brought together leaders from across healthcare, life sciences, and private capital.

Explore the Agenda

Discover the speakers and conversations shaping the sector’s future.

October 20

Reception | Ruka, 505 Washington Street, Boston, MA

October 21

Symposium | The Ritz-Carlton, Boston MA

Featured Insights

Generic laboratory setting with a glass pipette dispensing a drop of liquid into a test tube.
The Changing Pharma Services Landscape: Partnerships, Growth, and Global Challenges
Read More
Glass test tube in front of brightly colored DNA sequencing bands.
FDA Sharpens Its Pencil and Oversight Tools on Global Clinical Trial Data
Read More
Download the report
The New Playbook for Competitive Life Sciences M&A — How Buyers Can Differentiate Beyond Price Through Structure and Strategy
Read More
AI
Proprietary Data and Specialist AI: The Evolving Market in Life Sciences Transactions
Read More
Brain scan
Antitrust & Competition Healthcare 1H 2026 Update
Read More
Five
Five Trends Reshaping Pharmaceutical Manufacturing Partnerships
Read More
FTC HC
$46 Million Veloxis Settlement Yields Record Sunshine Penalty and Insights Into DOJ’s Cross-Agency Data Use
Read More
Biosecure
Final FY 2026 NDAA Includes BIOSECURE Act Provisions and New Opportunities for Biotech as DOD National Security Priority
Read More

Questions About the Symposium?

For questions about the program, please contact the Goodwin events team.